Federated Hermes
SPRB

Federated Hermes’s Spruce Biosciences SPRB Stock Holding History

Federated Hermes’s Portfolio SPRB Stock Details SPRB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-14
Closed -$2.28K – 2242
2023
Q1 		$2.28K Sell
14
-2
-13% -$371 ﹤0.01% 1995
2022
Q4 		$1.32K Buy
16
+1
+7% +$84 ﹤0.01% 2037
2022
Q3 		$2K Buy
15
+2
+15% +$280 ﹤0.01% 1990
2022
Q2 		$2K Buy
+13
New +$1.67K ﹤0.01% 2005

Other funds holding SPRB

NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
RVM
RiverVest Venture Management St. Louis, Missouri $6.84M AUM 7.71% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return

Federated Hermes's SPRB Position: Q2 2023 in Review

Federated Hermes sold out of Spruce Biosciences (SPRB) in Q2 2023, closing a stake of 14 shares — an estimated $2.28K sold.

Federated Hermes first reported a position in SPRB in Q2 2022 and held it in 4 quarters. The position peaked at $2.28K in Q1 2023. 38 funds tracked by Wall St. Rank hold SPRB as of Q2 2023.

  • Federated Hermes reported no remaining Spruce Biosciences position as of Q2 2023 after selling out during the quarter.
  • Federated Hermes sold 14 Spruce Biosciences shares in Q2 2023, an estimated $2.28K.
  • Federated Hermes first reported a position in Spruce Biosciences in Q2 2022 and held it in 4 quarters.
  • Federated Hermes's Spruce Biosciences position peaked at $2.28K in Q1 2023.
  • 38 funds tracked by Wall St. Rank held Spruce Biosciences as of Q2 2023.

Based on Federated Hermes's 13F filing for Q2 2023, filed 14 Aug 2023.